Neurocrine Biosciences (NBIX) Other Working Capital Changes (2011 - 2019)
Neurocrine Biosciences (NBIX) posted quarterly Other Working Capital Changes of -$78.8 million for Q2 2026, down 242.61% year-over-year from $55.3 million in Q2 2025, and down 350.96% on a QoQ basis from $31.4 million in Q1 2026.
Neurocrine Biosciences (NBIX) Other Working Capital Changes (2011 - 2019) Analysis & Trends
Neurocrine Biosciences has reported Other Working Capital Changes for 11 years, with the latest figure at -$78.8 million in Q2 2026.
- Other Working Capital Changes for Q2 2026 came in at -$78.8 million, down 242.61% year-over-year; the trailing twelve-month figure through Jun 2026 was $22.5 million (up 3.21% YoY), and the FY2025 annual result was $44.4 million, down 17.78% from the prior year.
- Other Working Capital Changes fell to -$78.8 million in Q2 2026, from $31.4 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $10.2 million in Q1 2015 and troughed at -$2.1 million in Q2 2019.
- A 5-year average of $1.3 million and a median of $441000.0 in 2018 frame the typical range for Other Working Capital Changes.
- The widest annual swing landed in 2025, when Other Working Capital Changes plunged 796.97%; it then surged 1356.0% in 2026.
- A 5-year view of Other Working Capital Changes shows it stood at -$3.5 million in 2022, then soared by 805.71% to $24.7 million in 2023, then rose by 15.38% to $28.5 million in 2024, then fell by 2.46% to $27.8 million in 2025, then slumped by 383.45% to -$78.8 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$78.8 million in Q2 2026, $31.4 million in Q1 2026, and $27.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 2.20 Mn |
| Sep 30, 2019 | 2.20 Mn |
| Sep 30, 2019 | 2.20 Mn |
| Jun 30, 2019 | -2.13 Mn |
| Jun 30, 2019 | -2.13 Mn |
| Jun 30, 2019 | -2.13 Mn |
| Mar 31, 2019 | 2.11 Mn |
| Mar 31, 2019 | 2.11 Mn |
| Mar 31, 2019 | 2.11 Mn |
| Sep 30, 2018 | -180,000.00 |
| Sep 30, 2018 | -180,000.00 |
| Sep 30, 2018 | -180,000.00 |
| Jun 30, 2018 | 2.45 Mn |
| Jun 30, 2018 | 2.45 Mn |
| Jun 30, 2018 | 2.45 Mn |
| Mar 31, 2018 | 441,000.00 |
| Mar 31, 2018 | 441,000.00 |
| Mar 31, 2018 | 441,000.00 |
| Dec 31, 2017 | -4.32 Mn |
| Dec 31, 2017 | -4.32 Mn |